Table 1

Comparison of results of telepsychiatric assessments and face-to-face interviews


Sample
 Accuracy Ratio Statistics
 Risk Difference Statistics
Primary attributes and accuracy
 A
 I
 Size
 AR
 LCI
 UCI
 p
 RD
 LCI
 UCI
 p
01
 DSM-IV Axis 1
 49
 5
 54
 0.91
 0.83
 0.99
 0.025
 -0.09
 -0.17
 -0.02
 0.019
02
 DSM-IV Axis 2
 34
 3
 37
 0.92
 0.84
 1.01
 0.083
 -0.08
 -0.17
 0.01
 0.071
03
 DSM-IV Axis 3
 36
 2
 38
 0.95
 0.88
 1.02
 0.157
 -0.05
 -0.12
 0.02
 0.146
04
 DSM-IV Axis 4 Q1
 31
 6
 37
 0.84
 0.73
 0.97
 0.014
 -0.16
 -0.28
 -0.04
 0.007
05
 DSM-IV Axis 4 Q2
 31
 6
 37
 0.84
 0.73
 0.97
 0.014
 -0.16
 -0.28
 -0.04
 0.007
06
 DSM-IV Axis 4 Q3
 37
 0
 37
 1.00
 1.00
 1.00
 NA
 0.00
 0.00
 0.00
 NA
07
 DSM-IV Axis 4 Q4
 36
 1
 37
 0.97
 0.92
 1.03
 0.317
 -0.03
 -0.08
 0.03
 0.311
08
 DSM-IV Axis 4 Q5
 37
 0
 37
 1.00
 1.00
 1.00
 NA
 0.00
 0.00
 0.00
 NA
09
 DSM-IV Axis 4 Q6
 32
 5
 37
 0.86
 0.76
 0.98
 0.025
 -0.14
 -0.25
 -0.02
 0.016
10
 DSM-IV Axis 4 Q7
 37
 0
 37
 1.00
 1.00
 1.00
 NA
 0.00
 0.00
 0.00
 NA
11
 DSM-IV Axis 4 Q8
 34
 3
 37
 0.92
 0.84
 1.01
 0.083
 -0.08
 -0.17
 0.01
 0.071
12
 DSM-IV Axis 4 Q9
 1
 36
 37
 0.03
 0.00
 0.19
 0.000
 -0.97
 -1.03
 -0.92
 0.000
13
 DSM-IV Axis 5
 26
 11
 37
 0.70
 0.57
 0.87
 0.001
 -0.30
 -0.44
 -0.15
 0.000
14
 Risk to Self Q1
 27
 10
 37
 0.73
 0.60
 0.89
 0.002
 -0.27
 -0.41
 -0.13
 0.000
15
 Risk to Self Q2
 29
 8
 37
 0.78
 0.66
 0.93
 0.005
 -0.22
 -0.35
 -0.08
 0.001
16
 Risk to Self Q3
 28
 9
 37
 0.76
 0.63
 0.91
 0.003
 -0.24
 -0.38
 -0.10
 0.001
17
 Risk to Self Q4
 28
 9
 37
 0.76
 0.63
 0.91
 0.003
 -0.24
 -0.38
 -0.10
 0.001
18
 Risk to Others Q1
 28
 9
 37
 0.76
 0.63
 0.91
 0.003
 -0.24
 -0.38
 -0.10
 0.001
19
 Risk to Others Q2
 35
 2
 37
 0.95
 0.88
 1.02
 0.157
 -0.05
 -0.13
 0.02
 0.146
20
 Risk to Others Q3
 33
 4
 37
 0.89
 0.80
 1.00
 0.046
 -0.11
 -0.21
 -0.01
 0.034
21
 Risk to Others Q4
 32
 5
 37
 0.86
 0.76
 0.98
 0.025
 -0.14
 -0.25
 -0.02
 0.016
22
 Risk to Others Q5
 33
 4
 37
 0.89
 0.80
 1.00
 0.046
 -0.11
 -0.21
 -0.01
 0.034
23
 Risk to Others Q6
 29
 8
 37
 0.78
 0.66
 0.93
 0.005
 -0.22
 -0.35
 -0.08
 0.001
24
 Admit-Discharge-Follow-up
 34
 3
 37
 0.92
 0.84
 1.01
 0.083
 -0.08
 -0.17
 0.01
 0.071
25
 Investigations
 25
 12
 37
 0.68
 0.54
 0.84
 0.001
 -0.32
 -0.48
 -0.17
 0.000
26
 Psychological Input
 26
 11
 37
 0.70
 0.57
 0.87
 0.001
 -0.30
 -0.44
 -0.15
 0.000
27
 Community Support
 29
 8
 37
 0.78
 0.66
 0.93
 0.005
 -0.22
 -0.35
 -0.08
 0.001
28
 Drug Type
 64
 11
 75
 0.85
 0.78
 0.94
 0.001
 -0.15
 -0.23
 -0.07
 0.000
29
 Drug Action
 58
 17
 75
 0.77
 0.68
 0.87
 0.000
 -0.23
 -0.32
 -0.13
 0.000
30
 Drug Indication
 49
 26
 75
 0.65
 0.55
 0.77
 0.000
 -0.35
 -0.45
 -0.24
 0.000
Main Attributes
31
 DSM-IV Axis 1 (1)
 49
 5
 54
 0.91
 0.83
 0.99
 0.025
 -0.09
 -0.17
 -0.02
 0.019
32
 DSM-IV Axis 2 (2)
 34
 3
 37
 0.92
 0.84
 1.01
 0.083
 -0.08
 -0.17
 0.01
 0.071
33
 DSM-IV Axis 3 (3)
 36
 2
 38
 0.95
 0.88
 1.02
 0.157
 -0.05
 -0.12
 0.02
 0.146
34
 DSM-IV Axis 4 (4:12)
 276
 57
 333
 0.83
 0.79
 0.87
 0.000
 -0.17
 -0.21
 -0.13
 0.000
35
 DSM-IV Axis 5 (13)
 26
 11
 37
 0.70
 0.57
 0.87
 0.001
 -0.30
 -0.44
 -0.15
 0.000
36
 Risk to Self (14:17)
 112
 36
 148
 0.76
 0.69
 0.83
 0.000
 -0.24
 -0.31
 -0.17
 0.000
37
 Risk to Others (18:23)
 190
 32
 222
 0.86
 0.81
 0.90
 0.000
 -0.14
 -0.19
 -0.10
 0.000
38
 Admit-Discharge-Follow-up (24)
 34
 3
 37
 0.92
 0.84
 1.01
 0.083
 -0.08
 -0.17
 0.01
 0.071
39
 Investigations (25)
 25
 12
 37
 0.68
 0.54
 0.84
 0.001
 -0.32
 -0.48
 -0.17
 0.000
40
 Psychological Input (26)
 26
 11
 37
 0.70
 0.57
 0.87
 0.001
 -0.30
 -0.44
 -0.15
 0.000
41
 Community Support (27)
 29
 8
 37
 0.78
 0.66
 0.93
 0.005
 -0.22
 -0.35
 -0.08
 0.001
42
 Drug Type (28)
 64
 11
 75
 0.85
 0.78
 0.94
 0.001
 -0.15
 -0.23
 -0.07
 0.000
43
 Drug Action (29)
 58
 17
 75
 0.77
 0.68
 0.87
 0.000
 -0.23
 -0.32
 -0.13
 0.000
44
 Drug Indication (30)
 49
 26
 75
 0.65
 0.55
 0.77
 0.000
 -0.35
 -0.45
 -0.24
 0.000
Major Attributes
45
 DSM Diagnosis (1:13)
 421
 78
 499
 0.84
 0.81
 0.88
 0.000
 -0.16
 -0.19
 -0.12
 0.000
46
 Risks (14:23)
 302
 68
 370
 0.82
 0.78
 0.86
 0.000
 -0.18
 -0.22
 -0.14
 0.000
47
 Non-Drug Intervention (24:27)
 114
 34
 148
 0.77
 0.71
 0.84
 0.000
 -0.23
 -0.30
 -0.16
 0.000
48
 Drug Intervention (28:30)
 171
 54
 225
 0.76
 0.71
 0.82
 0.000
 -0.24
 -0.30
 -0.18
 0.000
Overall
49
 Overall Result (1:30)
 1008
 234
 1242
 0.81
 0.79
 0.83
 0.000
 -0.19
 -0.21
 -0.17
 0.000

A: Accurate outcome, I: Inaccurate Outcome, AR: Accuracy Ratio (Risk Ratio), LCI: Lower 95% Confidence Interval, UCI: Upper 95% Confidence Interval, RD: Risk Difference when the sample statistics compared with Accuracy (Risk) of 1 for the face-to-face interview. All approximated p values are more than zero.

Numbers in brackets represent index number of primary attributes serialised in the previous rows.

Drug Types- Atypical Antipsychotic, Mood Stabilizer, Tricyclic Antidepressant, Newer Antidepressant, Other Antidepressant, Benzodiazepine Group, Non-Benzodiazepine Anxolytic, Anti-Parkinsonian, and 'No Medication'.

Drug related actions were grouped into 'New Prescription', 'Continuation of previously prescribed medication with no change', and 'Adjustment of previously prescribed medication'.

Drug Indications were categorised for Positive Psychotic Symptoms, Manic symptoms, Bipolar Disorder, Depression, Anxiety and Associated Symptoms, Drugs for Side Effects (e.g. Anti-parkinsonian), Hypnotics, and Use of Drugs' sedative effect for anxiety control and sleep.

Singh et al. BMC Psychiatry 2007 7:55   doi:10.1186/1471-244X-7-55